{"id":591022,"date":"2022-03-14T13:36:01","date_gmt":"2022-03-14T13:36:01","guid":{"rendered":"https:\/\/www.abnewswire.com\/pressreleases\/?p=591022"},"modified":"2022-03-14T13:36:01","modified_gmt":"2022-03-14T13:36:01","slug":"postoperative-nausea-and-vomiting-pipeline-drugs-key-companies-insight-report-analysis-of-clinical-trials-therapies-mechanism-of-action-route-of-administration-and-developments","status":"publish","type":"post","link":"https:\/\/www.abnewswire.com\/pressreleases\/postoperative-nausea-and-vomiting-pipeline-drugs-key-companies-insight-report-analysis-of-clinical-trials-therapies-mechanism-of-action-route-of-administration-and-developments_591022.html","title":{"rendered":"Postoperative Nausea and Vomiting Pipeline Drugs & Key Companies Insight Report: Analysis of Clinical Trials, Therapies, Mechanism of Action, Route of Administration, and Developments"},"content":{"rendered":"
\n
\"Postoperative<\/a><\/div>\n
\n
Postoperative Nausea and Vomiting Pipeline<\/div>\n<\/div>\n<\/div>\n
“Postoperative Nausea and Vomiting Pipeline Insight, 2022” report by DelveInsight outlays comprehensive insights of present clinical development scenario and growth prospects across the Postoperative Nausea and Vomiting market. A detailed picture of the Postoperative Nausea and Vomiting pipeline landscape is provided, which includes the disease overview and Postoperative Nausea and Vomiting treatment guidelines.<\/div>\n

DelveInsight’s “Postoperative Nausea and Vomiting Pipeline Insight” <\/a><\/strong>report provides comprehensive insights about key companies and pipeline drugs in the Postoperative Nausea and Vomiting pipeline landscapes. <\/p>\n

The report comprises Postoperative Nausea and Vomiting pipeline drug profiles, including clinical and non-clinical stage products. It also includes the Postoperative Nausea and Vomiting therapeutics assessment by product type, stage, route of administration, and molecule type and further highlights the inactive Postoperative Nausea and Vomiting pipeline products.     <\/p>\n

Postoperative Nausea and Vomiting Overview<\/strong><\/p>\n

Postoperative nausea and vomiting (PONV) is an enormous problem for patients recovering after surgery. About one-third of people experience vomiting, and half of them experience nausea. Nausea, retching, or vomiting usually occurs during the first 24–48 h after surgery in inpatients. Also, PONV is a common side effect following sedation and general anesthesia.<\/p>\n

The consequences of PONV can include increased anxiety for future surgical procedures, increased recovery time and hospital stay, and in severe cases, aspiration pneumonia, incisional hernia or suture dehiscence, bleeding esophageal rupture, and metabolic alkalosis. The causes of the PONV are related to the patient and preoperative, intraoperative, and postoperative factors such as pharyngeal stimulation, opioid medication, hypoxia, hypertension, etc.<\/p>\n

Some of the key takeaways from the Postoperative Nausea and Vomiting Pipeline Report:<\/a><\/strong><\/p>\n